Clinical Trials Browser

Phase 2 × Triple Negative Breast Neoplasms × Antilymphocyte Serum × Clear all

NCT01375023 2015-06-22

Allogenic Haematopoietic Cell Transplantation for Patients With Refractory "Triple Negative" Breast Cancer

Phase 2 Terminated

Breast Neoplasms, Triple Negative Breast Neoplasms